JP2008542367A5 - - Google Patents

Download PDF

Info

Publication number
JP2008542367A5
JP2008542367A5 JP2008514588A JP2008514588A JP2008542367A5 JP 2008542367 A5 JP2008542367 A5 JP 2008542367A5 JP 2008514588 A JP2008514588 A JP 2008514588A JP 2008514588 A JP2008514588 A JP 2008514588A JP 2008542367 A5 JP2008542367 A5 JP 2008542367A5
Authority
JP
Japan
Prior art keywords
alkyl
cyanomethyl
phenyl
carboxamide
quinoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008514588A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008542367A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2006/000630 external-priority patent/WO2006130080A2/en
Publication of JP2008542367A publication Critical patent/JP2008542367A/ja
Publication of JP2008542367A5 publication Critical patent/JP2008542367A5/ja
Pending legal-status Critical Current

Links

JP2008514588A 2005-06-03 2006-05-30 Nk−3アンタゴニストとしてのキノリン誘導体 Pending JP2008542367A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68741805P 2005-06-03 2005-06-03
PCT/SE2006/000630 WO2006130080A2 (en) 2005-06-03 2006-05-30 Quinoline derivatives as nk3 anatgonists

Publications (2)

Publication Number Publication Date
JP2008542367A JP2008542367A (ja) 2008-11-27
JP2008542367A5 true JP2008542367A5 (cg-RX-API-DMAC7.html) 2009-07-16

Family

ID=37482086

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008514588A Pending JP2008542367A (ja) 2005-06-03 2006-05-30 Nk−3アンタゴニストとしてのキノリン誘導体

Country Status (11)

Country Link
US (1) US20080200500A1 (cg-RX-API-DMAC7.html)
EP (1) EP1891012A2 (cg-RX-API-DMAC7.html)
JP (1) JP2008542367A (cg-RX-API-DMAC7.html)
KR (1) KR20080016591A (cg-RX-API-DMAC7.html)
CN (1) CN101189211A (cg-RX-API-DMAC7.html)
AU (1) AU2006253054A1 (cg-RX-API-DMAC7.html)
CA (1) CA2611060A1 (cg-RX-API-DMAC7.html)
IL (1) IL187410A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007014831A (cg-RX-API-DMAC7.html)
NO (1) NO20080033L (cg-RX-API-DMAC7.html)
WO (1) WO2006130080A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008131779A1 (en) 2007-04-26 2008-11-06 H. Lundbeck A/S Isoquinolinone derivatives as nk3 antagonists
US8173639B2 (en) 2007-04-26 2012-05-08 H. Lundbeck A/S Isoquinolinone derivatives as NK3 antagonists
AR072198A1 (es) 2008-06-23 2010-08-11 Lundbeck & Co As H Derivados de isoquinolinona como antagonistas de nk3 y composiciones farmaceuticas que los contienen
US8242134B2 (en) 2008-09-15 2012-08-14 H. Lundbeck A/S Isoquinolinone derivatives as NK3 antagonists
AR073891A1 (es) 2008-10-20 2010-12-09 Lundbeck & Co As H Derivados de isoquinolinona antagonistas de receptores nk3, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de psicosis, alzheimer y otras enfermedades.
TW201143768A (en) 2009-12-15 2011-12-16 Lundbeck & Co As H Pyridone derivatives as NK3 antagonists
TW201144311A (en) 2010-03-12 2011-12-16 Lundbeck & Co As H Azaisoquionolinone derivatives as NK3 antagonists
US10314835B2 (en) 2014-06-25 2019-06-11 Emory University Methods of managing conditioned fear with neurokinin receptor antagonists
KR20160069683A (ko) 2014-12-09 2016-06-17 백찬욱 콤비보트 및 그 제작 방법
US11458129B2 (en) 2017-11-02 2022-10-04 California Institute Of Technology Neurokinin antagonists and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69531458T2 (de) * 1994-05-27 2004-08-05 Glaxosmithkline S.P.A. Chinolinderivate als tachykinin nk3 rezeptor antagonisten
IT1270615B (it) * 1994-07-14 1997-05-07 Smithkline Beecham Farma Uso di derivati di chinolina
AR004735A1 (es) * 1995-11-24 1999-03-10 Smithkline Beecham Spa Quinoleina 4-amido sustituida, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso de los mismos para lapreparacion de un medicamento.
GB9524137D0 (en) * 1995-11-24 1996-01-24 Smithkline Beecham Spa Novel compounds
CN1264378A (zh) * 1997-05-23 2000-08-23 史密丝克莱恩比彻姆股份公司 作为nk-2和nk-3受体拮抗剂的喹啉-4-甲酰胺衍生物
AP1201A (en) * 1997-09-17 2003-09-01 Smithkline Beecham Corp Method for the synthesis of quinoline derivatives.
JP2002530377A (ja) * 1998-11-20 2002-09-17 スミスクライン・ビーチャム・ソシエタ・ペル・アチオニ Nk−3およびnk−2受容体アンタゴニストとしてのキノリン−4−カルボキシアミド誘導体
EP1385839B1 (en) * 2001-04-11 2006-02-22 GlaxoSmithKline S.p.A. 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
US20080280949A1 (en) * 2005-08-11 2008-11-13 Astrazeneca Ab Oxopyridyl Quinoline Amides as Nk3 Receptor Modulators
AR058051A1 (es) * 2005-09-21 2008-01-23 Astrazeneca Ab Quinolinas de alquilnitrilo.proceso de obtencion y composiciones farmaceuticas.
US20090054445A1 (en) * 2006-01-27 2009-02-26 Astrazeneca Ab Amide Substituted Quinolines

Similar Documents

Publication Publication Date Title
US8071621B2 (en) Alkylsulphonamide quinolines
JP2008542367A (ja) Nk−3アンタゴニストとしてのキノリン誘導体
JP2004525184A (ja) Nk−3およびnk−2受容体アンタゴニストとしての3−置換キノリン−4−カルボキサミド誘導体
CN101268053A (zh) 作为nk-3受体配体的烷基腈喹啉
US20080200504A1 (en) Amide Alkyl Pyridiyl Quinolines as Nk3 Receptor Modulators
CN101208304A (zh) 作为nk3受体调节剂的喹啉3-磺酸酯
CN101282964A (zh) 作为nk3受体调节剂的氧-吡啶基喹啉酰胺
CN101370782A (zh) 烷基磺酰胺喹啉
CN101268052A (zh) 作为nk-3受体配体的n-氧代-杂环和n-氧代-烷基喹啉-4-甲酰胺
US20080287492A1 (en) Alkylpyridyl Quinolines as Nk3 Receptor Modulators
KR20090122253A (ko) 퀴놀린 유도체, 이를 포함하는 제약 조성물, 및 중추신경계 및 말초 질환의 치료에서의 이의 용도
JP2009508946A (ja) Nk−3受容体リガンドとしてのアルキルスルホキシドキノリン類